ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EDEN Eden Research Plc

4.65
-0.10 (-2.11%)
29 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -2.11% 4.65 4.50 4.80 4.75 4.65 4.75 36,296 12:05:17
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -11.07 24.8M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.75p. Over the last year, Eden Research shares have traded in a share price range of 3.35p to 12.00p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £24.80 million. Eden Research has a price to earnings ratio (PE ratio) of -11.07.

Eden Research Share Discussion Threads

Showing 17101 to 17123 of 18100 messages
Chat Pages: Latest  688  687  686  685  684  683  682  681  680  679  678  677  Older
DateSubjectAuthorDiscuss
02/2/2024
10:44
Corteva sound to me like they are building themselves as 'differentiated' from the other big Ag players with their Biological portfolio which Eden play a part in with Ecovelex currently and no doubt other products inthecoming.
supersonico
02/2/2024
10:40
Well that is good to know, but at the moment, we are only in Italy on an EUA basis. You would hope that Corteva's presence and possible influence combined with regulatory direction of travel would see Ecovelex speed through the regulatory process in Europe, such that Eden wpuld contribute to the near-term biological goals that Corteva has set.

You would also hope this would be true on Sunflowers plus whatever else is in the works.

I Wonder where Eden sits in Corteva's third party biological crop protection input partners and therefore, how 'close' Corteva may get to Eden?

Can Corteva expedite approvals in a way that Eden can't and therefore expedite sales too?!

investingisatrickygame
02/2/2024
08:44
Investing,

Consider the USA now primed and poised for inthecoming.

$CTVA Corteva Q4 2023 Earnings Conference Call



@7:43
"We expect to increase our biological sales by double digits and nearly double earnings"

23:12
"and differentiated products including Biologicals would drive much of the crop protection growth in 2024 and 2025 as we move towards differentiation in 2 third of the crop protection".

30:11
"like I said whenyou think about our portfolio of new differentiated and biological is making up of you know nearly a majority of our entire uh earnings we think we're in a pretty good position to be able to price through this as we continue to work"

supersonico
02/2/2024
08:11
Super,

accepting that Skyline is promoting Eden, if Eden has done that well, you expect to see buys flowing through from US investors to validate those statements made. Let's hope that is so.

investingisatrickygame
02/2/2024
07:55
Sean in the USA.🏈 🏆🏈 🏆🏈 🏆🏈 🏆🏈

Skyline Corporate Communications Group, LLCView company: Skyline Corporate Communications Group, LLC


We're thrilled to announce our participation as proud sponsors of the largest independent event for microcaps – the 2024 DealFlow Events MicroCap Conference 🎉

Our team has been supporting our incredible clients at the forefront of the MicroCap Conference. A special shoutout to our amazing clients Pineapple, FingerMotion, Inc., and Eden Research plc for making strides in the spotlight during the conference!

Skyline Corporate Communications Group, LLC is your go-to, full-service, top-rated #investorrelations firm, boasting extensive experience and robust relationships with the market-leading #WallStreet #investment community.



............

Scott Powell

President & CEO, Skyline Corporate Communications Group, LLC; Vice President of Investor Relations at VolitionRx Limited (NYSE American: VNRX) & Chief Investment Officer at Volition America, Inc.


Thrilled to share that Skyline Corporate Communications Group, LLC is one of the proud sponsors for the 2024 DealFlow Events MicroCap Conference – the largest independent event for microcaps! 🎉

Our team and I have been right in the heart of the action, supporting our incredible clients who've been shining at the forefront of the MicroCap Conference. A special shoutout to some of our clients Pineapple, FingerMotion, Inc., and Eden Research plc for truly standing out during this event!

As the President of Skyline Corporate Communications Group, LLC, we are happy to be the top go-to, full-service, top-rated #InvestorRelations firm. We bring to the table extensive experience and robust relationships with the market-leading #WallStreet #investment community.

supersonico
02/2/2024
00:11
Neuts you seem like the worst sort of investor. I am talking about the kind of person who overreaches, can't accept their losses, and then blames just about everyone else but themselves. Do yourself a favour - learn from it and move on.
money never sleeps
01/2/2024
20:28
There is at least one infestation that needs treating and that's you and your foul, dirty lying mouth NPOV.
kittybiscuits
01/2/2024
19:38
Good suggestion, Brucie5, the greedy snouts in the BoD (motto: fcux the ordholders) are a bit fleabitten, lol! :D
neutralpov
01/2/2024
10:03
If EDEN could only develop an effective flea treatment for cats and muts, to replace the existing range of neurotoxins, they might do the world a great favour, while becoming the main/sole incumbent of very significant market. Sadly, we have heard very little/next to nothing about this since their proclamation about an imminent nits treatment. What happened?
brucie5
01/2/2024
09:38
Denominator for holdings and numbet for Marcap is now 533 million.
alchemy
31/1/2024
22:21
Thanks Super, my sock puppet. I am personally happy to wait for the next set of results to see how product sales are growing. But for anyone with the inclination , it would be interesting to look at how the overall target markets have grown in percentage terms with the new territories added in the last twelve months. I am also wondering whether the US market will be possibly easier to crack, given that it is geographically so concentrated within the State of California. It seems to me that should make things easier in terms of marketing, distribution and also word-of-mouth. The sales message can also leverage on the history of use in the EU too. All of which hopefully will all add up to a quicker ramp-up in sales than may be we have seen so far in Europe
money never sleeps
31/1/2024
19:28
It's still there in 'reactions'..he reposted / liked the Trading update post that Eden put up.
supersonico
31/1/2024
18:28
Super -
Please tell me, has the link you posted disappeared from Linked in? I didn't spot one when I looked just now.

#justiceforsingleIDs

money never sleeps
31/1/2024
18:07
What bloody evidence you blatant blathering idiot! You really have lost the plot
kittybiscuits
31/1/2024
17:04
##################################
# .............................. #
# PLACE-MARKER_004 FOR FCA / CPS #
# .............................. #
##################################

Evidence again the transgressors have been notified that their multi-I.D. racket run to deceive potential and existing investors is in breach of FSMA2024, and that their having been notified thereof will be an exacerbating factor. This applies equally to the paid and the unpaid rampers.

neutralpov
31/1/2024
13:26
With Eden looking to announce it's Insecticide partners inthecoming it's intriguing that Burghard Liebmann Director Global R&D Plant Health at FMC Corporation chooses now to make his first repost of an Eden announcement.





AWGATWT

supersonico
31/1/2024
13:00
Amati Buy = Fraudy now backs Eden as a BUY.

Who would have thought?

supersonico
31/1/2024
11:51
Increase in market cap over 19 months: 47.4%.Hope that helps.
swiftnick
31/1/2024
11:48
What is the share price on 31st January 2024. 5.975pHow many shares are on issue. 404,121,754Therefore what is the market capitalisation.GBP24,146,275
swiftnick
31/1/2024
11:44
What was the share price on 17th June 2022. 4.3pHow many shares were on issue. 380,858,607Therefore what was the market capitalisation.GBP16,376,920
swiftnick
31/1/2024
11:15
Thanks Best Guess.

I appreciate your best efforts to separate your mostly wrong Best Guesses from Fraudy's Amati Buy signal for Eden.

supersonico
31/1/2024
11:12
I think 8 figures a year is a very big turning point... if they were to ever get there.
timbo_slice
31/1/2024
10:52
I don't agree with any recommendation to buy Eden until they book significant $ seven figure sales. Per month.
ravenna23
Chat Pages: Latest  688  687  686  685  684  683  682  681  680  679  678  677  Older

Your Recent History

Delayed Upgrade Clock